Evvy, a women's health company focused on unlocking precision healthcare through novel female biomarkers, has secured $40.0M in new funding. The startup is pioneering a data-driven future in women's health, starting with the first at-home vaginal microbiome test to use metagenomic sequencing.
This capital will support Evvy's platform, which integrates state-of-the-art testing, precision clinical care, and 1:1 coaching. As one of the fastest-growing women's health companies in the US, Evvy is building real-world datasets to transform our understanding of complex female health conditions.
